Globe Life (GL) Stock
NEW YORK STOCK EXCHANGE, INC. · GL
167.92
Fundamentals
Market cap
$12.84B
Price / Earnings ratio
10.6x
Price / Sales ratio
2.1x
Price / Book ratio
2.1x
Return on assets
4.0%
Ex-Dividend date
6 Jul 2026
Last payment date
31 Jul 2026
Dividend amount
$0.33
Dividend yield
0.72%
Debt / Equity ratio
N/A
Recent news

Zacks Investment Research
Globe Life's Health Premium Growth Strengthens 2026 Outlook
NeutralGLSeptember 24, 2026
Zacks Investment ResearchNeutral
Globe Life's Health Premium Growth Strengthens 2026 Outlook
GL

Zacks Investment Research
GL Outperforms Industry, Trades at a Discount: How to Play the Stock
NeutralGLSeptember 18, 2026
Zacks Investment ResearchNeutral
GL Outperforms Industry, Trades at a Discount: How to Play the Stock
GL

Zacks Investment Research
Globe Life's Health Insurance Growth Powers Earnings Momentum
NeutralGLAugust 24, 2026
Zacks Investment ResearchNeutral
Globe Life's Health Insurance Growth Powers Earnings Momentum
GL

Zacks Investment Research
Globe Life (GL) Down 0.3% Since Last Earnings Report: Can It Rebound?
NeutralGLAugust 21, 2026
Zacks Investment ResearchNeutral
Globe Life (GL) Down 0.3% Since Last Earnings Report: Can It Rebound?
GL
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral2
Buy6
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
7B5B2B0
Debt & Balance Sheet
Total assets
Total liabilities
2025
37B24B12B0
Revenue to Profit
2025$6.0B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$1.2B
Net incomeEarnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

Zacks Investment Research
Globe Life's Health Premium Growth Strengthens 2026 Outlook
NeutralGLSeptember 24, 2026
Zacks Investment ResearchNeutral
Globe Life's Health Premium Growth Strengthens 2026 Outlook
GL

Zacks Investment Research
GL Outperforms Industry, Trades at a Discount: How to Play the Stock
NeutralGLSeptember 18, 2026
Zacks Investment ResearchNeutral
GL Outperforms Industry, Trades at a Discount: How to Play the Stock
GL

Zacks Investment Research
Globe Life's Health Insurance Growth Powers Earnings Momentum
NeutralGLAugust 24, 2026
Zacks Investment ResearchNeutral
Globe Life's Health Insurance Growth Powers Earnings Momentum
GL

Zacks Investment Research
Globe Life (GL) Down 0.3% Since Last Earnings Report: Can It Rebound?
NeutralGLAugust 21, 2026
Zacks Investment ResearchNeutral
Globe Life (GL) Down 0.3% Since Last Earnings Report: Can It Rebound?
GL

Zacks Investment Research
Globe Life Lags Industry, Trades at a Discount: Time to Buy or Hold?
NeutralGLAugust 17, 2026
Zacks Investment ResearchNeutral
Globe Life Lags Industry, Trades at a Discount: Time to Buy or Hold?
GL

Zacks Investment Research
4 Accident & Health Insurers to Watch Amid Elevated Healthcare Costs
NeutralGLAugust 11, 2026
Zacks Investment ResearchNeutral
4 Accident & Health Insurers to Watch Amid Elevated Healthcare Costs
GL

MarketBeat
Globe Life Q2 Earnings Call Highlights
NeutralGLJuly 23, 2026
MarketBeatNeutral
Globe Life Q2 Earnings Call Highlights
GL

Zacks Investment Research
Globe Life Q2 Earnings Miss Estimates on Escalating Expenses
NeutralGLJuly 23, 2026
Zacks Investment ResearchNeutral
Globe Life Q2 Earnings Miss Estimates on Escalating Expenses
GL

Zacks Investment Research
Compared to Estimates, Globe Life (GL) Q2 Earnings: A Look at Key Metrics
NeutralGLJuly 22, 2026
Zacks Investment ResearchNeutral
Compared to Estimates, Globe Life (GL) Q2 Earnings: A Look at Key Metrics
GL

Zacks Investment Research
Globe Life (GL) Q2 Earnings Lag Estimates
NeutralGLJuly 22, 2026
Zacks Investment ResearchNeutral
Globe Life (GL) Q2 Earnings Lag Estimates
GL
About Globe Life
Since 1951, Globe Life has grown in financial strength and reputation, providing insurance coverage for its millions of policyholders. Globe Life is committed to providing secure life insurance protection to their policyholders today and in the future. You can be assured Globe Life will be there when you need us the most.
SectorFinancial Services
IndustryInsurance - Life
Employees3,695
CEOMr. Frank Martin Svoboda
IPO DateDec 30, 1987
HeadquartersMcKinney, TX
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Frank Martin Svoboda | Co-Chairman & Co-CEO | 1962 |
| Mr. James Matthew Darden | Co-Chairman & Co-CEO | 1971 |
| Mr. Thomas Peter Kalmbach | Executive VP & CFO | 1965 |
| Mr. Robert Edward Hensley | Executive VP & Chief Investment Officer | 1968 |
| Mr. Robert Brian Mitchell J.D. | Executive VP, General Counsel & Chief Risk Officer | 1964 |
| Mr. Michael Clay Majors | Executive VP & Chief Strategy Officer | 1963 |
| Mr. M. Shane Henrie | Corporate Senior VP & Chief Accounting Officer | 1974 |
| Mr. Christopher Kyle Tyler | Executive VP & Chief Information Officer | 1974 |
| Ms. Dolores L. Skarjune | Executive VP & Chief Administrative Officer | 1966 |
| Mr. Stephen Mota | Vice President of Investor Relations | — |
Fundamentals
Valuation
Market cap$12.84B
Price-to-sales ratio2.08
Price-to-book value2.09
Price-earnings ratio10.60
Return on Equity20.00%
Return on Sales26.00%
Return on Assets4.00%
PEG ratio1.30
Earnings Per Share
Earnings Per Share$15.33
Income Statement
Average volume408,011
EBITDA$1.59B
1 year high (52w)$191.55
1 year low (52w)$127.85
Dividend
Ex dividend date6 Jul 2026
Dividend amount$0.33
Dividend yield0.72%
Last payment date31 Jul 2026
Dividend yield (TTM)0.39%
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
What the experts say
8 Wall Street Analyst Ratings
BUY
75% Buy
25% Hold
0% Sell
Target price
$194.88
Est return
17.02%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -1.2 | -1.4 | -5.4 | +9.9 | ||||||||
| 2022 | +7.8 | -1.7 | +3.7 | -2.4 | -0.5 | +0.2 | +0.4 | -1.9 | +2.2 | +13.2 | +5.0 | +0.1 |
| 2023 | +1.1 | +1.2 | -9.6 | -0.9 | -5.3 | +5.6 | +1.7 | -0.9 | -2.4 | +7.2 | +5.8 | -1.3 |
| 2024 | +0.6 | +5.7 | -7.8 | -33.3 | +4.1 | -0.2 | +12.0 | +13.0 | +0.7 | +1.8 | +6.9 | +1.3 |
| 2025 | +8.8 | +4.1 | +2.4 | -6.7 | +3.5 | +1.7 | +12.5 | +2.0 | +2.2 | -6.7 | +3.1 | +5.5 |
| 2026 | +1.3 | +1.3 | -4.9 | +9.9 | +0.3 | +17.5 | +1.2 | -6.2 | -3.1 |
Corporate actions
Upcoming
DividendQ4/26
Ex-dividend date5 Oct 2026
Payable date30 Oct 2026
Amount per share$0.33
Past
DividendQ3/26
Ex-dividend date6 Jul 2026
Payable date31 Jul 2026
Amount per share$0.33
DividendQ2/26
Ex-dividend date2 Apr 2026
Payable date1 May 2026
Amount per share$0.33



